醫師介紹
醫師學術論文
Paper陳碩爵 Shuo-Chueh Chen 主治醫師
陳碩爵醫師曾在台大醫院內科受訓,之後在其恩師洪瑞松教授建議下回母校服務。目前是胸腔內科專責主治醫師,專長肺癌診療 (包含標靶治療,免疫治療,化學治療),肺阻塞,氣喘,肺炎,及肺纖維化症。更在本校臨床醫學研究所從事肺癌基礎及臨床研究,取得博士學位。陳醫師醫術精湛,又具有親和力,頗獲病患及家屬肯定;對醫學教育亦頗有心得。陳醫師同時也在草屯及豐原分院看診,提供當地民眾醫學中心級的服務。
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 花俊宏(Chun-Hung Hua)、(Chun-Yi Chuang)、簡義忠(Yi-Chung Chien)、(Chun-Wen Su)、陳碩爵(Shuo-Chueh Chen)、劉良智(Liang-Chih Liu)、(Shun-Fa Yang)*、余永倫(Yung-Luen Yu)*,Analysis of MUC6 polymorphisms on the clinicopathologic characteristics of Asian patients with oral squamous cell carcinoma,JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2023 Sep,27(17):2594-2602 | 2023 . 09 |
2 | (Chuang CY)、(Chien YC)、(Lin CW)、(Chou CH)、陳碩爵(Shuo-Chueh Chen)、(Liu CL)、白禮源(Li-Yuan Bai)、(Yang SF)*、余永倫(Yung-Luen Yu)*,TRIM21 Polymorphisms are associated with Susceptibility and Clinical Status of Oral Squamous Cell Carcinoma patients,International Journal of Medical Sciences,2021 Jun,18(13):2997-3003 | 2021 . 06 |
3 | (Hsiang-Lin Lee)、簡義忠(Chien, Yi-Chung)、(Whei-Ling Chiang)、(Hsiang-Ling Wang)、(Kuan-Chun Hsueh)、陳肇烜(Chao-Hsuan Chen)、陳碩爵(Shuo-Chueh Chen)、(Tsai-Kun Wu)、(Ying-Ru Pan)、白禮源(Li-Yuan Bai)*、(Shun-Fa Yang)*、余永倫(Yung-Luen Yu)*,Analysis of TRIM21 Genetic Variants on the Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma,Processes,2021 Mar,9(3):495 | 2021 . 03 |
4 | 陳鴻仁(Hung-Jen Chen)、涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、方信元(Hsin-Yuan Fang)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、李嘉翔(Chia-Hsiang Li)、廖裕民(Yu-Min Liao)、謝清昀(Ching-Yun Hsieh)、連銘渝(Ming-Yu Lien)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)*,Prognostic Significance of Oligometastatic Disease Classification by the ESTRO/EORTC of Cancer for Patients With Lung Cancer Treated With Definitive Radical Radiotherapy,ANTICANCER RESEARCH,2020 Oct,40(10):5895-5899 | 2020 . 10 |
5 | 廖哲琦(LIAO CHE-CHI)、林昱森(Yu-Sen Lin)、林裕超(Yu-Chao Lin)、鄭喬仁(Chiao-Jen Cheng)、陳碩爵(Shuo-Chueh Chen)*,A rare case of synchronous multiple primary lung cancer with different response to gefitinib,Respiratory Medicine Case Reports,2020 Oct,31(2020):101270-101270 | 2020 . 10 |
6 | 陳鴻仁(Hung-Jen Chen)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、林宏霖(Hung-Lin Lin)、夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、杭良文(Liang-Wen Hang)、鄭文建(Wen-Chien Cheng)、李佳瑾、簡君儒(Chun-Ru Chien)*,Focal conformal fractionated radiotherapy vs. radiosurgery for lung cancer patients with limited brain metastases,Annals of Palliative Medicine,2020 Sep,9(5):2600-2605 | 2020 . 09 |
7 | 林裕超(Yu-Chao Lin)、陳碩爵(Shuo-Chueh Chen)*,Cavity with ball-in-hole lesion in the lung (WOS文章性質: Editorial Material),European Journal of Internal Medicine,2016 Feb,16():22-24 | 2016 . 02 |
8 | 夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、陳鴻仁(Hung-Jen Chen)、陳碩爵(Shuo-Chueh Chen)、梁基安(Ji-An Liang)、陳志毅(Chih-Yi Chen)、王耀慶(Yao-Ching Wang)*、簡君儒(Chun-Ru Chien)*,A Population-based Study of Primary Chemoradiotherapy in Clinical Stage III Non-small Cell Lung Cancer: Intensity-modulated Radiotherapy Versus 3D Conformal Radiotherapy,ANTICANCER RESEARCH,2014 Sep,34():5175-5180 | 2014 . 09 |
9 | 陳致宇(Chih-Yu Chen)、程味兒(Wei-Erh Cheng)*、林哲弘(Che-Hung Liu)、陳碩爵(Shuo-Chueh Chen)、施純明(Chuen-Ming Shih),Tadpoles in the Lungs: Cement Pulmonary Embolism Complicating Vertebroplasty of Spinal Metastasis,AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE,2014 Aug,190(3):340-341 | 2014 . 08 |
10 | 程味兒(Wei-Erh Cheng)、蘇莉婷(Li-Ting Su)、陳碩爵(Shuo-Chueh Chen)、李采娟(Tsai-Chung Li)、林香汶(Margaret Hsiang-Wen Lin)*,Economic burden of diabetes mellitus on respiratory failure patients requiring mechanical ventilation during hospitalizations,Value in Health Regional Issues,2014 May,*(3):33-38 | 2014 . 05 |
11 | 陳碩爵(Shuo-Chueh Chen)、簡義忠(Yi-Chung Chien)、潘俊旭(Chun-Hsu Pan)、許志宏(Jyh-Horng Sheu)*、陳志毅(Chih-Yi Chen)*、吳介信(Chieh-Hsi Wu)*,Inhibitory Effect of Dihydroaustrasulfone Alcohol on the Migration of Human Non-Small Cell Lung Carcinoma A549 Cells and the Antitumor Effect on a Lewis Lung Carcinoma-Bearing Tumor Model in C57BL/6J Mice,Marine Drugs,2014 Jan,12(1):196-213 | 2014 . 01 |
12 | 郭武憲(Wu-Hsien Kuo)、施純明(Chuen-Ming Shih)*、林巧雯(Chiao-Wen Lin)、程味兒(Wei-Erh Cheng)、陳碩爵(Shuo-Chueh Chen)、陳煒(Wei- Chen)、李瑤玲(Yao-Ling Lee)*,Association of Hypoxia Inducible Factor-1α Polymorphisms with Susceptibility to Non-small Cell Lung Cancer,Translational Research,2012 Jan,159(1):42-50 | 2012 . 01 |
13 | 陳碩爵(Shuo-Chueh Chen)*、張仕妮(Shih-Ni Chang)、程味兒(Wei-Erh Cheng)、陳志毅(Chih-Yi Chen)、徐武輝(Wu-Huei Hsu)、林裕超(Yu-Chao Lin)、邱國樑(Kuo-Liang Chiu)、梁信杰(Shinn-Jye Liang)、魏裕峰(Yu-Feng Wei)、劉炯勳(Jiung-Hsiun Liu)、宋鴻樟(Fung-Chang Sung)、施純明(Chuen-Ming Shih),Cirrhosis is a Crucial Factor in Mortality and Medical Costs of Acute Respiratory and Renal Failure Patients,胸腔醫學,2012 ,27(4):199-208 | 2012 . |
14 | 李瑤玲(Yao-Ling Lee)、郭武憲(Wu-Hsien Kuo)、林巧雯(Chiao-Wen Lin)、陳煒(Wei- Chen)、程味兒(Wei-Erh Cheng)、陳碩爵(Shuo-Chueh Chen)、施純明(Chuen-Ming Shih)*,Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.,LUNG CANCER,2011 Aug,73(2):147-152 | 2011 . 08 |
15 | 陳碩爵(Shuo-Chueh Chen)、施純明(Chuen-Ming Shih)、曾冠欽(Guan-Chin Teseng)、程味兒(Wei-Erh Cheng)、邱勤(Jean Chiou)、蕭宏昇(Michael Hsiao)、郭明良(Min Liang Kuo)、蘇振良(Jen-Liang Su)*、陳志毅(Chih-Yi Chen)*,Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor,ANNALS ACADEMY OF MEDICINE SINGAPORE,2011 Jul,40(7):319-324 | 2011 . 07 |
16 | 施純明(Chuen-Ming Shih)、郭武憲(Wu-Hsien Kuo)、林巧雯(Chiao-Wen Lin)、陳煒(Wei Chen)、程味兒(Wei-Erh Cheng)、陳碩爵(Shuo-Chueh Chen)、李瑤玲(Yao-Ling Lee)*,Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer,CLINICA CHIMICA ACTA,2011 Jan,412(0):194-198 | 2011 . 01 |
17 | 陳碩爵(Shuo-Chueh Chen)、劉峻成(Juhn-Cherng Liu)、曾冠欽(Guan-Chin Teseng)、陳志毅(Chih-Yi Chen)*,Rare Presentation of Pulmonary Cryptococcosis as Calcified Nodule,Internal Medicine,2011 Jan,(50):169-170 | 2011 . 01 |
18 | 沈煥庭(Huan-Ting Shen)、陳碩爵(Shuo-Chueh Chen)*、程味兒(Wei-Erh Cheng)、邱國樑(KUO-LIANG CHIU)、施純明(Chuen-Ming Shih)、徐武輝(Wu-Huei Hsu),Negative Pressure Pulmonary Edema Related to Deep Neck Infection-A Case Report,胸腔醫學,2010 ,25(3):125-130 | 2010 . |
19 | 陳碩爵(Shuo-Chueh Chen)、程味兒(Wei-Erh Cheng)*、施純明(Chuen-Ming Shih)、朱家成(Chia-Chen Chu)、劉金蓉(Chin-Jung Liu),Adaptive Support Ventilation: Review of the Literature and Clinical Applications,內科學誌,2008 Dec,19(6):465-471 | 2008 . 12 |
20 | 陳碩爵(Shuo-Chueh Chen)、施純明(Chuen-Ming Shih)*、蘇振良(Jen-Liang Su)、葉士芃(Shih-Peng Yeh)、陳家弘(Chia-Hung Chen)、曾冠欽(Guan-Chin Teseng)、徐武輝(Wu-Huei Hsu)、程味兒(Wei-Erh Cheng)、林育生(Yu-Sheng Lin)、蔡育霖(Yu-Lin Tsai),Anaplastic Large-Cell Lymphoma Presenting As an Endobronchial Polypoid Tumor,JOURNAL OF CLINICAL ONCOLOGY,2008 Sep,(): | 2008 . 09 |
21 | 謝逸憲(Hsieh YS)、李瑤玲(Lee YL)、楊昇翰(Yang SF)、楊順發(Yang JS)、陳煒(Wei- Chen)、陳碩爵(Shuo-Chueh Chen)、施純明(Chuen-Ming Shih)*,Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.,LUNG CANCER,2007 Nov,58(2):191-195 | 2007 . 11 |
22 | 陳碩爵(Shuo-Chueh Chen)、陳煒(Wei- Chen)、徐武輝(Wu-Huei Hsu)、余養豪(Yang-Hao Yu)、施純明(Chuen-Ming Shih)*,Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated perapneumonic effusions from complicated parapneumonic effusions and empyema,LUNG,2006 Oct,(184):141-145 | 2006 . 10 |
23 | 陳碩爵(Shuo-Chueh Chen)、何茂旺(Mao-Wang Ho)*、涂智彥(Chih-Yen Tu)、白培英(Pei-Ying Pai)、施純明(Chuen-Ming Shih),Pulmonary arterial hypertension related to human immunodeficiency virus infection: a case report and literature review,胸腔醫學,2006 Jun,21(3):261-267 | 2006 . 06 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | Pleura Detection in Chest Computed Tomography with Application,35th Annual International Conference of the IEEE EMBS,Osaka, Japan,,2013.07.02~2013.07.07, | 2013 . 07 |
2 | Vascular endothelial growth factor C is a predictor of early recurrence and poor prognosis of resected stage I non-small cell lung cancer in Taiwan,ERS BARCELONA 2010 ANNUAL CONGRESS SPAIN,BARCELONA, Spain,2010.09.18~2010.09.22, | 2010 . 09 |
3 | The impact of diabetes mellitus on healthcare costs in taiwanese patients with respiratory failure,ERS BARCELONA 2010 ANNUAL CONGRESS,BARCELONA, Spain,2010.09.18~2010.09.22, | 2010 . 09 |
4 | Cirrhotic patients complicated with acute renal and respiratory failure indicated a higher mortality and daily cost than other major diseases - a natinal health insurance analysis in Taiwan,ERS Barcelona 2010 annual congress,Barcelona, Spain,2010.09.18~2010.09.22, | 2010 . 09 |
5 | Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer,ERS BARCELONA 2010 ANNUAL CONGRESS,BARCELONA, Spain,2010.09.18~2010.09.22, | 2010 . 09 |
6 | Vascular Endothelial Growth Factor C is a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung Cancer,台灣胸腔暨重症加護醫學會年會,林口長庚醫院,2009.12.12~2009.12.13, | 2009 . 12 |
7 | Tissue inhibitors of metalloproteinase-2 C-303T and G-418C genetic polymorphisms are associated with an increased risk of non-small cell lung cancer in Taiwan,European Respiratory Society Annual Congress歐洲呼吸年會,德國柏林,2008.10.04~2008.10.08, | 2008 . 10 |
8 | The Ventilatory Responses during Maximal Exercise in Adults with Metabolic Syndrome,2008年美國胸腔醫學會年會,加拿大多倫多,2008.05.16~2008.05.21, | 2008 . 05 |
9 | Chest Ultrasound dimpling sign predicting the pleural invasion by peripheral lung cancer,2008年美國胸腔醫學會年會,加拿大多倫多,2008.05.16~2008.05.21, | 2008 . 05 |
10 | Association of p53 codon 72 polymorphism with risk of lung cancer in taiwan,11th congress of the asian pacific society of respirology(APSR),日本京都,2006.11~ , | 2006 . 11 |
11 | The role of pleural fluid c-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema,ATS International Conference Committee,美國聖地牙哥,2006.05~ , | 2006 . 05 |
12 | The role of pleural fluid c-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema,American thoracic society 2006 international conference,美國聖地牙哥,2006.05~ , | 2006 . 05 |
13 | The role of pleural fluid c-reactive protein concentration in discriminating uncomplicated parapneumonic effusion and empyema,台灣胸腔暨重症加護醫學會94年度會員大會暨學術研討會,台灣台北市,2005.12~ , | 2005 . 12 |
14 | Polymorphism in the p53 and p21 promoter are associated with susceptibility to COPD,Eur Respir J,丹麥哥本哈根,2005.09~ , | 2005 . 09 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,DMR-112-024,余永倫(Yung-Luen Yu),附醫院內計畫,分析特發性肺纖維化肺癌風險與危險因子之機轉探討,2022.8.1~2023.7.31 | 2022 . 08 |
2 | 臨床試驗與研究計畫,CMUH105-REC1-088,梁信杰(Liang, Shinn-Jye)、陳碩爵(Chen, Shuo-Chueh),附醫廠商計畫,一項24週、雙盲、雙模擬、隨機分配、多國、多中心、2組平行組別、活性對照的臨床試驗,比較以吸入劑pMDI (CHF 5993) beclometasone dipropionate和formoterol fumarate以及glycopyrrolate bromide固定複方,相對於budesonide和formoterol fumarate固定複方(Symbicort® Turbuhaler®),治療慢性阻塞性肺病病患的情形,2017.1.1~2017.12.31 | 2017 . 01 |
3 | 臨床試驗與研究計畫,CMUH104-REC1-069,李嘉翔(Li, Chia-Hsiang)、林裕超(Lin, Yu-Chao)、涂智彥(Tu, Chih-Yen)、梁信杰(Liang, Shinn-Jye)、陳家弘(Chen, Chia-Hung)、陳碩爵(Chen, Shuo-Chueh)、程味兒(Cheng, Wei-Erh)、廖偉志(Liao, Wei-Chih)、顏至慶(Yen, Chih-Ching),附醫廠商計畫,一項隨機分配、雙盲、安慰劑對照、平行組研究,在持續性氣喘(persistent asthma)患者中評估dupilumab的療效與安全性,2017.1.1~2017.12.31 | 2017 . 01 |
4 | 臨床試驗與研究計畫,CMUH106-REC2-095,梁信杰(Liang, Shinn-Jye)、陳碩爵(Chen, Shuo-Chueh)、廖偉志(Liao, Wei-Chih),附醫廠商計畫,台灣特發性肺纖維化族群(IPF)之非介入性研究,2017.1.1~2017.12.31 | 2017 . 01 |
5 | 臨床試驗與研究計畫,CMUH106-REC3-040,廖偉志(Liao, Wei-Chih)、陳碩爵(Chen, Shuo-Chueh)、梁信杰(Liang, Shinn-Jye)、余養豪(Yu, Yang-Hao),附醫廠商計畫,一項前瞻性、流行病學、多國、群組研究,評估在亞太地區的中度至極重度慢性阻塞性肺病(COPD)病人於穩定的COPD及COPD急性發作(AECOPD)期間之可能細菌和病毒病原體的發生率。,2017.1.1~2017.12.31 | 2017 . 01 |
6 | 臨床試驗與研究計畫,CMUH104-REC1-029,涂智彥(Tu, Chih-Yen)、顏至慶(Yen, Chih-Ching)、梁信杰(Liang, Shinn-Jye)、陳碩爵(Chen, Shuo-Chueh)、陳家弘(Chen, Chia-Hung)、李嘉翔(Li, Chia-Hsiang)、廖偉志(Liao, Wei-Chih)、林裕超(Lin, Yu-Chao),附醫廠商計畫,一項評估肺部慢性綠膿桿菌感染非囊性纖維化支氣管擴張病患以Pulmaquin®處置之安全性與療效的多中心、隨機分配、雙盲、安慰劑對照試驗,包括28日開放性延伸期與藥動學子試驗(ORBIT-3),2017.1.1~2017.12.31 | 2017 . 01 |
7 | 臨床試驗與研究計畫,CMUH103-REC1-028,涂智彥(Chih-Yen Tu)、陳碩爵(Shuo-Chueh Chen)、陳家弘(Chia-Hung Chen)、顏至慶(Chih-Ching Yen)、梁信杰(Shinn-Jye Liang)、陳偉峻(Wei-Chun chen)、林裕超(Yu-Chao Lin)、吳秉儒(Biing-Ru Wu),附醫廠商計畫,一項為期 12 週的試驗,針對慢性阻塞性肺病 (COPD) 患者,使用每日一次 Fluticasone Furoate/Vilanterol (FF/VI) 100/25 mcg 吸入性乾粉,或每日一次 Vilanterol (VI) 25 mcg 吸入性乾粉,比較其療效和安全性,2016.1.1~2016.12.31 | 2016 . 01 |
8 | 臨床試驗與研究計畫,CMUH105-REC1-088,梁信杰(Shinn-Jye Liang)、陳碩爵(Shuo-Chueh Chen),附醫廠商計畫,一項24週、雙盲、雙模擬、隨機分配、多國、多中心、2組平行組別、活性對照的臨床試驗,比較以吸入劑pMDI (CHF 5993) beclometasone dipropionate和formoterol fumarate以及glycopyrrolate bromide固定複方,相對於budesonide和formoterol fumarate固定複方(Symbicort® Turbuhaler®),治療慢性阻塞性肺病病患的情形,2016.1.1~2016.12.31 | 2016 . 01 |
9 | 臨床試驗與研究計畫,CMUH105-REC1-040,涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、梁信杰(Shinn-Jye Liang)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、程味兒(Wei-Erh Cheng)、李嘉翔(Chia-Hsiang Li)、林裕超(Yu-Chao Lin)、廖偉志(Wei-Chih Liao),附醫廠商計畫,一項多中心、隨機分配、雙盲、安慰劑對照試驗,目的為評估當控制不良的嚴重氣喘病患接受QAW039加上現有的氣喘療法,治療52週的療效與安全性,2016.1.1~2016.12.31 | 2016 . 01 |
10 | 臨床試驗與研究計畫,CMUH103-REC2-015,涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、梁信杰(Shinn-Jye Liang)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、陳偉峻(Wei-Chun chen)、林裕超(Yu-Chao Lin)、吳秉儒(Biing-Ru Wu),附醫廠商計畫,一項為期 24 週之隨機分配、雙盲、安慰劑對照試驗,評估Umeclidinium 62.5 mcg 吸入性乾粉,用於慢性阻塞性肺病患者以新型乾粉吸入器每日投藥一次之療效與安全性,2016.1.1~2016.12.31 | 2016 . 01 |
11 | 臨床試驗與研究計畫,CMUH104-REC1-052,涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、程味兒(Wei-Erh Cheng)、梁信杰(Shinn-Jye Liang)、陳碩爵(Shuo-Chueh Chen)、陳家弘(Chia-Hung Chen)、林裕超(Yu-Chao Lin)、廖偉志(Wei-Chih Liao)、李嘉翔(Chia-Hsiang Li),附醫廠商計畫,一個為期52週、多中心、隨機分配、雙盲、平行組別、安慰劑對照組之第3期試驗,以評估Tralokinumab對於患有氣喘且已接受吸入性皮質類固醇併用長效型β2促效劑但無法有效控制的成人及青少年之療效與安全性(STRATOS 1),2016.1.1~2016.12.31 | 2016 . 01 |
12 | 臨床試驗與研究計畫,CMUH104-REC1-029,涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、梁信杰(Shinn-Jye Liang)、陳碩爵(Shuo-Chueh Chen)、陳家弘(Chia-Hung Chen)、李嘉翔(Chia-Hsiang Li)、廖偉志(Wei-Chih Liao)、林裕超(Yu-Chao Lin),附醫廠商計畫,一項評估肺部慢性綠膿桿菌感染非囊性纖維化支氣管擴張病患以Pulmaquin®處置之安全性與療效的多中心、隨機分配、雙盲、安慰劑對照試驗,包括28日開放性延伸期與藥動學子試驗(ORBIT-3),2016.1.1~2016.12.31 | 2016 . 01 |
13 | 臨床試驗與研究計畫,CMUH104-REC1-121,涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、程味兒(Wei-Erh Cheng)、梁信杰(Shinn-Jye Liang)、陳碩爵(Shuo-Chueh Chen)、陳家弘(Chia-Hung Chen)、林裕超(Yu-Chao Lin)、廖偉志(Wei-Chih Liao)、李嘉翔(Chia-Hsiang Li),附醫廠商計畫,一項多國多中心、隨機分派、雙盲、雙虛擬、長期給藥 (56週) 安慰劑對照、平行分組之第三期試驗,以評估 3 種劑量之 benralizumab (MEDI-563) 對於中度至極重度慢性阻塞性肺病 (COPD) 且有急性發作病史患者之療效與安全性 (TERRANOVA),2016.1.1~2016.12.31 | 2016 . 01 |
14 | 臨床試驗與研究計畫,CMUH103-REC2-078,涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、梁信杰(Shinn-Jye Liang)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、陳偉峻(Wei-Chun chen)、林裕超(Yu-Chao Lin)、廖偉志(Wei-Chih Liao),附醫廠商計畫,安慰劑對照,併用Mepolizumab治療COPD經常急性發作並有一定數量嗜酸性白血球之患者。,2016.1.1~2016.12.31 | 2016 . 01 |
15 | 整合型項下子計畫(主持人),NSC 102-2325-B-002-087,陳家弘(Chia-Hung Chen)、涂智彥(Chih-Yen Tu)、顏至慶(Chih-Ching Yen)、梁信杰(Shinn-Jye Liang)、陳碩爵(Shuo-Chueh Chen)、陳偉峻(Wei-Chun chen)、廖偉志(Wei-Chih Liao),科技部,台灣慢性阻塞性肺病臨床試驗合作聯盟(Ⅱ),2013.5.1~2014.4.30 | 2013 . 05 |
16 | 個別型,DMR-100-130,陳碩爵(Shuo-Chueh Chen),附醫院內計畫,C型血管內皮生長因子是為第一期非小細胞肺癌術後早期復發及預後不良之預測因子,2010.8.1~2011.7.31 | 2010 . 08 |